Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 5P30AI064518-20 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
The purpose of this study is to evaluate a pilot program that provides Pre-Exposure Prophylaxis (PrEP) for people who use drugs (PWUD) and are at risk for contracting HIV. Given the ongoing overdose crisis and the risk of HIV among PWUD, this study aims to assess weather offering oral PrEP on a Medical Mobile Unit (MMU) is a viable strategy for preventing HIV transmission in high-risk populations. The other goal of this study is to assess community perceptions of PrEP and perceived HIV risk among Syringe Service Program (SSP) clients visiting a MMU.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PrEP | Experimental | All eligible participants will be given oral PrEP pills to reduce their risk for contracting HIV. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pre-Exposure Prophylaxis (PrEP) | Drug | Oral Pre-Exposure Prophylaxis (PrEP) pills |
|
| Measure | Description | Time Frame |
|---|---|---|
| Enrollment | Number of participants utilizing medical mobile unit during study duration who are eligible for PrEP | Baseline |
| Negative HIV Status | Number of participants who remain HIV negative at 3 months (Measured via negative HIV test at 3 months | up to 3 months |
| PrEP Consultation | Number of participants who agree to PrEP consultation | up to 6 months |
| PrEP Initiation | Number of participants who complete PrEP consultation and start PrEP | up to 6 months |
| Retention | Number of participants who come back for 3 month and 6 month visit | up to 6 months |
| Follow Through | Number of participants who pick up PrEP medication | up to 6 months |
| Negative HIV Status at 6 months | Number of participants who remain HIV negative at 6 months (Measured via negative HIV test at 6 months) | up to 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Amelia R Ashkin-Baker, BA | Contact | (919)448-8680 | amelia.ashkin-baker@duke.edu | |
| Madelene Travis, BA | Contact | madelene.travis@duke.edu |
| Name | Affiliation | Role |
|---|---|---|
| Mehri McKellar, MD | Duke Health | Principal Investigator |
| Jacqueline Hodges, MD, MPH | Duke Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Duke Department of Population Health Sciences | Recruiting | Durham | North Carolina | 27701 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
Not provided
Not provided
| ID | Term |
|---|---|
| D065129 | Pre-Exposure Prophylaxis |
| ID | Term |
|---|---|
| D011322 | Primary Prevention |
| D011314 | Preventive Health Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D015980 | Public Health Practice |
| D011634 | Public Health |
| D004778 | Environment and Public Health |